Pharma & Biotech

Ocugen’s stock has been on a rollercoaster, sliding 25% over the past month to trade at €1.18, but the company...

Eli Lilly closed last week with a flurry of news that turned the stock into a tale of two catalysts....

Assembly Biosciences has emerged from the EASL Congress in Barcelona with more than just data. The biotech firm capped a...

Eli Lilly has barrelled past a historic threshold, becoming the first pharmaceutical company to reach a market capitalisation of $1...

Despite sitting on nearly $20 billion in cash, BioNTech is burning through money at an accelerating pace as it races...

Ocugen is making quiet but meaningful progress across its pipeline of gene therapy programmes, yet the stock tells a more...

Ocugen has closed a $115 million convertible note offering that buys the biotech group more than two years of operating...

The era of pandemic-era blockbuster revenues at BioNTech has come to a definitive end. The Mainz-based biotech is shuttering four...

Shares of AbCellera Biologics have been on a tear, climbing nearly 11% on Monday to €3.88 and pushing year-to-date gains...

Novo Nordisk closed the week with a bang, its shares surging 6.7% to €35.16 on Friday. But beneath that single-day...